The American Journal of Managed Care

GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...

Artiva Biotherapeutics Prioritizes Refractory Rheumatoid Arthritis as Lead Indication for AlloNK (AB-101)

Artiva Biotherapeutics Inc. (NASDAQ: ARTV) is one of the Reddit stocks that will go to the moon. On October 16, Artiva ...

Orthopaedic surgeon warns ‘being pain-free does not mean your arthritis is gone’; shares 5 myths and facts

Orthopaedic surgeon Dr Bajwa outlines misconceptions and facts about arthritis, including its impact on all age groups and ...

Artiva Biotherapeutics (ARTV): Valuation Snapshot Following FDA Fast Track for AlloNK in Refractory Rheumatoid Arthritis

Artiva Biotherapeutics, a US-based biotech firm, saw its stock make headlines after the US Food and Drug Administration granted Fast Track Designation to its AlloNK therapy in combination with ...